Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29176 - 29200 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dasatinib	Approved Investigational	NCAPD3	23310	downregulated	Dasatinib results in decreased expression of NCAPD3 mRNA	11q25	A21899
Dasatinib	Approved Investigational	NCAPG	64151	downregulated	Dasatinib results in decreased expression of NCAPG mRNA	4p15.31	A21899
Dasatinib	Approved Investigational	NCAPG2	54892	downregulated	Dasatinib results in decreased expression of NCAPG2 mRNA	7q36.3	A21899
Dasatinib	Approved Investigational	NCAPH	23397	downregulated	Dasatinib results in decreased expression of NCAPH mRNA	2q11.2	A21899
Dasatinib	Approved Investigational	NCEH1	57552	downregulated	Dasatinib results in decreased expression of NCEH1 mRNA	3q26.31	A21899
Dasatinib	Approved Investigational	NDC1	55706	downregulated	Dasatinib results in decreased expression of NDC1 mRNA	1p32.3	A21899
Dasatinib	Approved Investigational	NDC80	10403	downregulated	Dasatinib results in decreased expression of NDC80 mRNA	18p11.32	A21899
Dasatinib	Approved Investigational	NEFM	4741	downregulated	Dasatinib results in decreased expression of NEFM mRNA	8p21.2	A21899
Dasatinib	Approved Investigational	NEMP1	23306	downregulated	Dasatinib results in decreased expression of NEMP1 mRNA	12q13.3	A21899
Dasatinib	Approved Investigational	NEO1	4756	upregulated	Dasatinib results in increased expression of NEO1 mRNA	15q24.1	A21899
Dasatinib	Approved Investigational	NNMT	4837	upregulated	Dasatinib results in increased expression of NNMT mRNA	11q23.1	A21899
Dasatinib	Approved Investigational	NREP	9315	upregulated	Dasatinib results in increased expression of NREP mRNA	5q22.1	A21899
Dasatinib	Approved Investigational	NRP2	8828	upregulated	Dasatinib results in increased expression of NRP2 mRNA	2q33.3	A21899
Dasatinib	Approved Investigational	NRXN3	9369	upregulated	Dasatinib results in increased expression of NRXN3 mRNA	14q31	A21899
Dasatinib	Approved Investigational	NSD2	7468	downregulated	Dasatinib results in decreased expression of NSD2 mRNA	4p16.3	A21899
Dasatinib	Approved Investigational	NUAK1	9891	upregulated	Dasatinib results in increased expression of NUAK1 mRNA	12q23.3	A21899
Dasatinib	Approved Investigational	NUSAP1	51203	downregulated	Dasatinib results in decreased expression of NUSAP1 mRNA	15q14	A21899
Dasatinib	Approved Investigational	ORC1	4998	downregulated	Dasatinib results in decreased expression of ORC1 mRNA	1p32.3	A21899
Dasatinib	Approved Investigational	ORC6	23594	downregulated	Dasatinib results in decreased expression of ORC6 mRNA	16q11.2	A21899
Dasatinib	Approved Investigational	PARPBP	55010	downregulated	Dasatinib results in decreased expression of PARPBP mRNA	12q23.2	A21899
Dasatinib	Approved Investigational	PBK	55872	downregulated	Dasatinib results in decreased expression of PBK mRNA	8p21.1	A21899
Dasatinib	Approved Investigational	PBX1	5087	upregulated	Dasatinib results in increased expression of PBX1 mRNA	1q23.3	A21899
Dasatinib	Approved Investigational	PCK2	5106	upregulated	Dasatinib results in increased expression of PCK2 mRNA	14q11.2-q12	A21899
Dasatinib	Approved Investigational	PCLAF	9768	downregulated	Dasatinib results in decreased expression of PCLAF mRNA	15q22.31	A21899
Dasatinib	Approved Investigational	PCMTD1	115294	upregulated	Dasatinib results in increased expression of PCMTD1 mRNA	8q11.23	A21899

Displaying entries 29176 - 29200 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability